Canton Strategic Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Canton Strategic Holdings Inc.
- Former names
- Tharimmune, Inc. Hillstream BioPharma Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 6199 — Finance Services
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CNTN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001861657
- EIN
- 84-2642541
Board of directors
-
Gary S. Stetz · DirectorSince 2025
-
James Gordon Liddy · DirectorSince 2025
-
Jill E. Sommers · DirectorSince 2026
-
Kelly Anderson · DirectorSince 2023
-
Leonard L. Mazur · DirectorSince 2023
-
Lynne A. Bui · DirectorSince 2023
-
Nancy Davis Rickel · DirectorSince 2025
-
Pamela L. Carter · DirectorSince 2026
-
Randy Milby · Director · CEOSince 2023
-
Rishi Nangalia · DirectorSince 2026
-
Sanam Parikh · Director · COOSince 2024
-
Sean Galvin · DirectorSince 2026
-
Sireesh Appajosyula · Director · CEOSince 2023
-
Thomas Clay Kahler · DirectorSince 2025
-
Vincent S. LoPriore · Director · Executive ChairmanSince 2025
-
William Thomas Wiley Jr. · DirectorSince 2026
Chief executives
Randy Milby
· CEO
Dates unknown
Sireesh Appajosyula
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of July 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.9%
-
100.0%
-
100.0%
-
100.0%
-
100.0%
Board connections
4 of this board's directors also sit on 9 other boards.
- via Kelly Anderson
- via Pamela L. Carter
- via Leonard L. Mazur
- via Leonard L. Mazur
- via Pamela L. Carter
- via Jill E. Sommers
- via Jill E. Sommers
- via Jill E. Sommers
- via Kelly Anderson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $343,882
- 8 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 26, 2026 | Gary S. Stetz Director | Open-market sale | −12,500 | $3.47 | $43,375 |
| May 22, 2026 | Gary S. Stetz Director | Open-market sale | −10,000 | $3.45 | $34,500 |
| May 22, 2026 | Gary S. Stetz Director | Open-market sale | −10,000 | $3.45 | $34,500 |
| May 22, 2026 | Gary S. Stetz Director | Open-market sale | −15,000 | $3.40 | $51,000 |
| May 22, 2026 | Gary S. Stetz Director | Open-market sale | −15,000 | $3.41 | $51,150 |
| May 22, 2026 | Gary S. Stetz Director | Open-market sale | −15,000 | $3.41 | $51,150 |
| May 22, 2026 | Gary S. Stetz Director | Open-market sale | −10,000 | $3.40 | $34,000 |
| May 22, 2026 | Gary S. Stetz Director | Open-market sale | −12,851 | $3.44 | $44,207 |
| Jun 23, 2025 | Kelly Anderson Director | Grant or award | +6,300 | — | — |
| Jun 20, 2025 | Gravitas Capital LP Director, Officer (Executive Chairman), 10% owner | Open-market purchase | +337,838 | $1.48 | $500,000 |
| Jun 20, 2025 | Sanam Parikh Director | Open-market purchase | +1,000 | $1.45 | $1,450 |
| Jun 20, 2025 | Sireesh Appajosyula Director, Officer (Chief Executive Officer) | Open-market purchase | +60,806 | $1.48 | $89,993 |
| Jun 20, 2025 | Sireesh Appajosyula Director, Officer (Chief Executive Officer) | Open-market purchase | +690 | $1.42 | $980 |
| May 15, 2025 | Sanam Parikh Director | Open-market purchase | +770 | $1.30 | $1,001 |
| Dec 19, 2024 | Randy Milby Director, Officer (CEO) | Open-market purchase | +4,600 | $2.12 | $9,752 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.